A rare gastrointestinal cancer is rising sharply among Gen X and Millennials, prompting experts to call for more research.

Over the past few decades, antibiotics have been used more frequently, both in medicine and in agriculture. This widespread ...

Experts worry about the uptick in cases as more Gen Xers and millennials are being diagnosed with a variety of ...

Though extremely rare, cancers of the appendix are being diagnosed at higher rates in Gen X and millennials compared with earlier cohorts.

The FDA has approved a revised label for Merck’s immunotherapy drug Keytruda, limiting its use in some gastrointestinal cancer treatments to patients whose tumors express a minimum level of PD-L1 ...